IBN SINA Pharmaceutical Industry Ltd (TISN)

Currency in BDT
308.00
-1.10(-0.36%)
Closed·
TISN Scorecard
Full Analysis
Stock generally trades with low price volatility
TISN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
306.70312.00
52 wk Range
267.00384.80
Key Statistics
Prev. Close
290.4
Open
307.6
Day's Range
306.7-312
52 wk Range
267-384.8
Volume
32.81K
Average Volume (3m)
33.57K
1-Year Change
1.05%
Book Value / Share
120.55
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TISN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
375.00
Upside
+21.75%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

IBN SINA Pharmaceutical Industry Ltd Company Profile

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflammatory, anti-allergic-occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, anti-fibrinolytic, anti-fungal, anti-glucoma, anti-histamine, anti-malarial, anti-melasma, anti-neuropathic, anti-protozoal, anti-spasmodic, anti-ulcerant, antibacterial, antibiotic, anticataract, anti-diabetic, antigout, anti-helmintic, antimigraine agent, antisecretory, antivertigo agent, and antiviral products. In addition, the company’s therapeutic products comprise antibiotic and steroid, antibiotic-occular, antifungal-occular, antiviral-occular, anxiolytic and antidepressant, aromatase inhibitor, bile acid, bisphosphonates, calcium supplement, cardiovascular preparation, cholinesterase inhibitor, corticosteroid, cough expectorant, dry eye syndrome, gastroprokinetic agent, haematinic/vitamin and mineral, hand rub, hormone products, intestinal anti-inflammatory, laxative, multivitamin and multi-minerals, muscle relaxant, mydriatic agents, nasal decongestant, neuroleptic, nootropic, NSAIDS, NSAIDS-occular, ORS, steroid-occular, topical, urological preparation, urinary incontinence, and sodium-glucose co-transporter inhibitor products. Further, it provides herbal and Unani products; and manufactures and trades in active pharmaceutical ingredients, natural medicines, polymer plastic bottles, plastic tubes, laminated tubes, and other related products. The company was incorporated in 1983 and is headquartered in Dhaka, Bangladesh.

Employees
4200

Compare TISN to Peers and Sector

Metrics to compare
TISN
Peers
Sector
Relationship
P/E Ratio
15.2x20.2x−0.5x
PEG Ratio
−1.85−0.540.00
Price/Book
2.6x1.5x2.6x
Price / LTM Sales
0.8x2.6x3.3x
Upside (Analyst Target)
21.3%42.5%41.6%
Fair Value Upside
Unlock12.2%5.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 375.00
(+21.75% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 20.25%
Dividend Yield
2.05%
Industry Median 4.01%
Annualised payout
6.30
Paid annually
5-Years Growth
+16.00%
Growth Streak

Earnings

Latest Release
May 28, 2025
EPS / Forecast
5.60 / --
Revenue / Forecast
2.88B / --
EPS Revisions
Last 90 days

TISN Income Statement

FAQ

What Stock Exchange Does IBN SINA Pharma Trade On?

IBN SINA Pharma is listed and trades on the Dhaka Stock Exchange stock exchange.

What Is the Stock Symbol for IBN SINA Pharma?

The stock symbol for IBN SINA Pharma is "TISN."

What Is the IBN SINA Pharma Market Cap?

As of today, IBN SINA Pharma market cap is 9.62B.

What Is IBN SINA Pharma's Earnings Per Share (TTM)?

The IBN SINA Pharma EPS (TTM) is 20.25.

When Is the Next IBN SINA Pharma Earnings Date?

IBN SINA Pharma will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is TISN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has IBN SINA Pharma Stock Split?

IBN SINA Pharma has split 11 times.

How Many Employees Does IBN SINA Pharma Have?

IBN SINA Pharma has 4200 employees.

What is the current trading status of IBN SINA Pharma (TISN)?

As of 13 Aug 2025, IBN SINA Pharma (TISN) is trading at a price of 308.00, with a previous close of 290.40. The stock has fluctuated within a day range of 306.70 to 312.00, while its 52-week range spans from 267.00 to 384.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.